Disruption of the APC gene by t(5;7) translocation in a Turcot family

详细信息    查看全文

• 作者：Nora Sahnane^a ; ^{n.sahnane@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Barbara Bernasconi^a ; Ileana Carnevali^b ; Daniela Furlan^a ; Alessandra Viel^c ; Fausto Sessa^a ; Maria Grazia Tibiletti^b
• 关键词：Turcot syndrome ; APC ; conventional karyotype ; MLPA ; FISH ; digital PCR
• 刊名：Cancer Genetics
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：209
• 期：3
• 页码：107-111
• 全文大小：527 K

文摘

Turcot syndrome (TS) refers to the combination of colorectal polyps and primary tumours of the central nervous system. TS is a heterogeneous genetic condition due to APC and/or mismatch repair germline mutations. When APC is involved the vast majority of mutations are truncating, but in approximately 20%–30% of patients with familial polyposis no germline mutation can be found. A 30-year-old Caucasian woman with a positive pedigree for TS was referred to our Genetic Counselling Service. She was negative for APC and MUTYH but showed a reciprocal balanced translocation t(5;7)(q22;p15) at chromosome analysis. FISH analysis using specific BAC probes demonstrated that 5q22 breakpoint disrupted the APC gene. Transcript analysis by MLPA and digital PCR revealed that the cytogenetic rearrangement involving the 3′ end of the APC gene caused a defective expression of a truncated transcript. This result allowed cytogenetic analysis to be offered to all the other family members and segregation analysis clearly demonstrated that all the carriers were affected, whereas non-carriers did not have the polyposis. A cytogenetic approach permitted the identification of the mutation-causing disease in this family, and the segregation analysis together with the transcript study supported the pathogenetic role of this mutation. Karyotype analysis was used as a predictive test in all members of this family. This family suggests that clinically positive TS and FAP cases, which test negative with standard molecular analysis, could be easily and cost-effectively resolved by a classical and molecular cytogenetic approach.